Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection
Related Experiment Video
Updated: Sep 22, 2025

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Olivia Maslac1,2, Josef Wagner1, Vitina Sozzi1
1Division of Molecular Research and Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Insights
Hepatitis B virus (HBV) splice variants vary by genotype and disease phase in chronic hepatitis B (CHB). These variants, particularly Sp1 and Sp13, were more frequent in immune-active phases and associated with lower functional cure rates.
Area of Science:
- Virology
- Hepatology
- Genomics
Background:
- Chronic hepatitis B (CHB) involves distinct phases of hepatitis B virus (HBV) infection.
- HBV splice variants, though not essential for replication, are increasingly linked to liver disease progression.
- Previous studies lacked data on HBV splice variant diversity across genotypes and CHB phases.
Purpose of the Study:
- To investigate the frequency and diversity of HBV splice variants in CHB patients.
- To analyze variants across different HBV genotypes (A, B, C, D) and CHB phases (I, II, IV).
- To explore the association of splice variants with clinical outcomes like HBeAg levels and HBsAg loss.
Main Methods:
- Analysis of next-generation sequencing data from 404 CHB patient samples.
- Utilized an in-house bioinformatics pipeline to identify HBV splice variants.
- Categorized samples by HBV genotype and CHB phase (I, II, IV).
Main Results:
- HBV splice variants showed significant differences in frequency and type based on genotype and CHB phase.
- Splice variant Sp1 was detected in 51% of patients, followed by Sp13 in 37%.
- Variant frequency was highest in Phase II (75%) and Phase I (70%), associated with immune activation.
- Sp1 and Sp13 were linked to reduced HBeAg levels and lower likelihood of HBsAg loss (functional cure) in Phase II patients.
Conclusions:
- HBV splice variant prevalence differs significantly by HBV genotype and CHB phase.
- Increased detection of splice variants in Phase II warrants further investigation due to its association with immune activity.
- Findings highlight the clinical relevance of HBV splice variants in CHB pathogenesis and treatment outcomes.
Abstract:
Chronic hepatitis B (CHB) is characterized by progression through different phases of hepatitis B virus (HBV) infection and disease. Although not necessary for HBV replication, there is increasing evidence that HBV splice variants are associated with liver disease progression and pathogenesis. However, there have been no studies till date on the frequency or diversity of splice variants for different HBV genotypes across the phases of CHB. Next generation sequencing data from 404 patient samples of HBV genotype A, B, C or D in Phase I, Phase II or Phase IV of CHB was analysed for HBV splice variants using an in house bioinformatics pipeline. HBV splice variants differed in frequency and type by genotype and phase of natural history. Splice variant Sp1 was the most frequently detected (206/404, 51% of patients), followed by Sp13 (151/404 37% of patients). The frequency of variants was generally highest in Phase II (123/165, 75% of patients), a phase typically associated with enhanced immune activation, followed by Phase I (69/99, 70% of patients). Splice variants were associated with reduced hepatitis B e antigen (HBeAg) levels and statistically reduced likelihood of achieving HBsAg loss (functional cure) in Phase II patients for Sp1 and Sp13 (p = .0014 and .0156, respectively). The frequency of HBV splice variants in patient serum differed markedly by HBV genotype and phase of CHB natural history. The increased levels of HBV splice variants detected in CHB phase II patients compared with the higher replicative Phase I in particular warrants further investigation.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Viruses with RNA Genomes
RNA Splicing
Leaky Scanning
Subviral Agents
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Retroviruses